STOCK TITAN

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
ANI Pharmaceuticals, Inc. will release its second quarter 2023 financial results on August 9, 2023. The conference call to discuss the results will be hosted by President and CEO Nikhil Lalwani and CFO Stephen P. Carey. The call details are as follows: Date: August 9, 2023, Time: 8:30 a.m. ET, Toll-free (U.S.): 800-267-6316, Webcast: www.anipharmaceuticals.com (under 'Investors' section). A replay of the call will be available for two weeks by dialing 800-839-2461, access code: 119757.
Positive
  • None.
Negative
  • None.

BAUDETTE, Minn., July 31, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its second quarter 2023 financial results on Wednesday, August 9, 2023, prior to the market open.

Nikhil Lalwani, President and Chief Executive Officer, and Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, will host a conference call to discuss the results as follows:

DateWednesday, August 9, 2023
Time8:30 a.m. ET
Toll free (U.S.)800-267-6316
Webcast (live and replay)www.anipharmaceuticals.com, under the “Investors” section

A replay of the conference call will be available within two hours of the call’s completion and will remain accessible for two weeks by dialing 800-839-2461 and entering access code 119757.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products, including for diseases with high unmet medical need. Our team is focused on delivering sustainable growth by scaling up our Rare Disease business through the successful launch of our lead asset, Purified Cortrophin® Gel, strengthening our generics business with enhanced development capability, innovation in established brands and leveraging our North American manufacturing capabilities. For more information, please visit our website www.anipharmaceuticals.com.

Investor Relations Contact:
Lisa M. Wilson, In-Site Communications, Inc.
212-452-2793
lwilson@insitecony.com

SOURCE: ANI Pharmaceuticals, Inc.


FAQ

When will ANI Pharmaceuticals release its second quarter 2023 financial results?

ANI Pharmaceuticals will release its second quarter 2023 financial results on Wednesday, August 9, 2023.

Who will host the conference call to discuss the results?

The conference call to discuss the results will be hosted by Nikhil Lalwani, President and CEO, and Stephen P. Carey, CFO.

What are the details of the conference call?

The conference call will take place on Wednesday, August 9, 2023, at 8:30 a.m. ET. The toll-free number for participants in the U.S. is 800-267-6316. The webcast can be accessed on www.anipharmaceuticals.com, under the 'Investors' section.

How can I access the replay of the conference call?

The replay of the conference call will be available within two hours of the call's completion. To access the replay, dial 800-839-2461 and enter the access code 119757. The replay will remain accessible for two weeks.

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

ANIP Rankings

ANIP Latest News

ANIP Stock Data

1.28B
20.96M
11.16%
87.02%
9.74%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
BAUDETTE